All News

New research indicates that veterans who played a diabetes education game in teams demonstrated greater improvements in blood glucose control than veterans who learned about diabetes management from a booklet.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

Atopic dermatitis (AD) presents a significant humanistic burden on the quality of life among adult patients. Due to its public health impact and negative symptoms, the development for new and more effective treatments are necessary.

Large employers that self-insure can avoid the tax, but that option is off limits to small businesses like restaurants or convenience stores.

The discovery capitalizes on years of work to understand immune system pathways that lead to the destruction of beta cells in type 1 diabetes.

A new report from the Kaiser Family Foundation examines preliminary data on premium rates and plan offerings on the Affordable Care Act’s exchanges.

The Institute for Clinical and Economic Review (ICER) has released a draft version of their scoping document that will compare the clinical effectiveness and value of 2 chimeric antigen receptor (CAR)-T cell treatments being reviewed by the FDA.

MimiVax announced that its immunotherapy vaccine SurVaxM, which is being tested in clinical trials for glioblastoma, has been designated an orphan drug by the FDA.

Prescription opioids, intended for post-surgery utilization, often go unused and undisposed, leading to the nonmedical use of opioids that could have harmful consequences.

Two clinical-community interventions-enhanced primary care and enhanced primary care with coaching-are capable of improving parent-reported outcomes and a child's quality of life for childhood obesity.

The results of a phase 2 study that explored the effects of luspatercept in patients with lower-risk myelodysplastic syndromes (MDS) were presented at the 22nd Congress of the European Hematology Association by Acceleron Pharma Inc. The company is developing the drug with Celgene.

In the first of a series from the Digestive Health Physicians Association, Dr Lawrence R. Kosinski writes about Project Sonar, an innovative proposed Advanced APM that has cleared the first regulatory step. Project Sonar has saved thousands in hospitalization costs in pilot studies.

Researchers have highlighted physician education as a potential solution for the opioid epidemic, based on their findings that attending a top-ranked medical school is associated with writing far fewer opioid prescriptions.

Patient-reported outcomes have demonstrated the impact of sarilumab as an effective management treatment for patients with rheumatoid arthritis.

Treatment decisions could be assisted through molecular profiling, which would allow patients and oncologists to evaluate the biological features of the tumor.

Attention-deficit/hyperactivity disorder is a common and impairing condition for adults, but it often remains undiagnosed. Researchers sought to develop a new way to screen for the disorder among adults.

Will right-to-try improve patient access to investigational drugs?

The review reports that fewer than 50% of patients with diabetes are being treated according guidelines to prevent a cardiovascular event.

Patrick Conway, MD, MSc, will leave his position as the deputy administrator for Innovation and Quality at CMS and the director of the Center for Medicare and Medicaid Innovation to lead Blue Cross and Blue Shield of North Carolina (Blue Cross NC).

Removing outdated systems and using offsite backup strategies are keys to protecting a health system from ransomware attacks, which are on the rise.

New research has identified a gene that enables paclitaxel to spread cancer to the lungs even as it shrinks tumors in the breast.

A study used health data to show that low birth weight babies of all races that lived in areas dominated by African Americans faced the same elevated risk of asthma.

A new study indicates that drugs approved through the FDA’s expedited review programs offer larger health gains than those approved via the traditional review process.

Eczema is often assumed to be a childhood disease; however, the skin condition also affects adults and its prevalence is continually increasing. About half as many adults are affected by eczema than children, but it can negatively influence their quality of life.

New research has found that the steady increase in the price of targeted oral anticancer medications is washing out the potential for savings that patients would experience in their out-of-pocket payments following closure of the Medicare Part D coverage gap.

A phase 3 study of a new treatment for chronic obstructive pulmonary disease (COPD) found no new safety issues, and the rates of adverse events and serious adverse events were minimal.

Amidst news of Senator John McCain’s glioblastoma diagnosis, a recent discussion between 2 neuro-oncology researchers explored the reasons why this aggressive brain tumor is so difficult to manage, and outlined the ongoing investigations into possible therapies.